| 摘要 |
The methods disclosed herein relate to the treatment of chronic pulmonary disorders, such as for example asthma, COPD, cough, bronchial hyperactivity and bronchitis, in human patients, by administering a therapeutically effective amount of RS-norketotifen. |
